{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:08:33Z","timestamp":1784261313100,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.amepre.2018.12.003","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T13:28:46Z","timestamp":1555507726000},"page":"875-881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["U.S. National 90-Day Readmissions After Opioid Overdose Discharge"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7955-0977","authenticated-orcid":false,"given":"Cora","family":"Peterson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Likang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Nataraj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"Mikosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.amepre.2018.12.003_bib0001","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1111\/add.13795","article-title":"Hospitalizations, costs and outcomes associated with heroin and prescription opioid overdoses in the United States 2001\u201312","volume":"112","author":"Hsu","year":"2017","journal-title":"Addiction"},{"issue":"12","key":"10.1016\/j.amepre.2018.12.003_bib0002","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1513\/AnnalsATS.201701-022OC","article-title":"The critical care crisis of opioid overdoses in the United States","volume":"14","author":"Stevens","year":"2017","journal-title":"Ann Am Thorac Soc"},{"issue":"10","key":"10.1016\/j.amepre.2018.12.003_bib0003","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1377\/hlthaff.2017.0260","article-title":"Opioid abuse and poisoning: trends in inpatient and emergency department discharges","volume":"36","author":"Tedesco","year":"2017","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/j.amepre.2018.12.003_bib0004","series-title":"Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","article-title":"Opioid-related inpatient stays and emergency department visits by state, 2009\u20132014: Statistical Brief #219","author":"Weiss","year":"2016"},{"issue":"2","key":"10.1016\/j.amepre.2018.12.003_bib0005","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11414-013-9323-5","article-title":"Hospital readmission among Medicaid patients with an index hospitalization for mental and\/or substance use disorder","volume":"40","author":"Mark","year":"2013","journal-title":"J Behav Health Serv Res"},{"issue":"1","key":"10.1016\/j.amepre.2018.12.003_bib0006","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/ADM.0b013e318231de51","article-title":"Acute care hospital utilization among medical inpatients discharged with a substance use disorder diagnosis","volume":"6","author":"Walley","year":"2012","journal-title":"J Addict Med"},{"issue":"5","key":"10.1016\/j.amepre.2018.12.003_bib0007","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1097\/ALN.0000000000002136","article-title":"Opioid abuse or dependence increases 30-day readmission rates after major operating room procedures: a national readmissions database study","volume":"128","author":"Gupta","year":"2018","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.amepre.2018.12.003_bib0008","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/jhm.2113","article-title":"Prevalence and characteristics of hospitalized adults on chronic opioid therapy","volume":"9","author":"Mosher","year":"2014","journal-title":"J Hosp Med"},{"issue":"8","key":"10.1016\/j.amepre.2018.12.003_bib0009","doi-asserted-by":"crossref","first-page":"e0182900","DOI":"10.1371\/journal.pone.0182900","article-title":"Factors associated with readmission to the hospital within 30 days in patients with inflammatory bowel disease","volume":"12","author":"Micic","year":"2017","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.amepre.2018.12.003_bib0010","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/phar.1902","article-title":"Characterizationand management of patients with heroin versus nonheroin opioid overdoses: experience at an academic medical center","volume":"37","author":"Morizio","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"4","key":"10.1016\/j.amepre.2018.12.003_bib0011","doi-asserted-by":"crossref","first-page":"E503","DOI":"10.36076\/ppj.2014\/17\/E503","article-title":"Opioid tolerance \u2013 a predictor of increased length of stay and higher readmission rates","volume":"17","author":"Gulur","year":"2014","journal-title":"Pain Physician"},{"key":"10.1016\/j.amepre.2018.12.003_bib0012","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1146\/annurev-publhealth-031914-122957","article-title":"The prescription opioid and heroin crisis: a public health approach to an epidemic of addiction","volume":"36","author":"Kolodny","year":"2015","journal-title":"Annu Rev Public Health"},{"issue":"8","key":"10.1016\/j.amepre.2018.12.003_bib0013","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1001\/jamapsychiatry.2018.1471","article-title":"Causes of death after nonfatal opioid overdose","volume":"75","author":"Olfson","year":"2018","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.amepre.2018.12.003_bib0014","series-title":"Introduction to the HCUP Nationwide Readmissions Database (NRD)","year":"2017"},{"issue":"11","key":"10.1016\/j.amepre.2018.12.003_bib0015","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1097\/MLR.0000000000000805","article-title":"Trends in opioid-related inpatient stays shifted after the U.S. transitioned to ICD-10-CM diagnosis coding in 2015","volume":"55","author":"Heslin","year":"2017","journal-title":"Med Care"},{"key":"10.1016\/j.amepre.2018.12.003_bib0016","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jsat.2018.06.008","article-title":"U.S. hospital discharges documenting patient opioid use disorder without opioid overdose or treatment services, 2011\u20132015","volume":"92","author":"Peterson","year":"2018","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.amepre.2018.12.003_bib0017","series-title":"Beta Elixhauser Comorbidity Software for ICD-10-CM","year":"2018"},{"key":"10.1016\/j.amepre.2018.12.003_bib0018","series-title":"A comparison of all-cause 7-day and 30-day readmissions, 2014: Statistical Brief #230. Healthcare Cost and Utilization Project (HCUP) Statistical Briefs","author":"Fingar","year":"2006"},{"issue":"4","key":"10.1016\/j.amepre.2018.12.003_bib0019","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1111\/dar.12448","article-title":"A systematic review of the prevalence of comorbid mental health disorders in people presenting for substance use treatment in Australia","volume":"36","author":"Kingston","year":"2017","journal-title":"Drug Alcohol Rev"},{"issue":"6","key":"10.1016\/j.amepre.2018.12.003_bib0020","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1192\/bjp.bp.107.045732","article-title":"Quality of medical care for people with and without comorbid mental illness and substance misuse: systematic review of comparative studies","volume":"194","author":"Mitchell","year":"2009","journal-title":"Br J Psychiatry"},{"issue":"1","key":"10.1016\/j.amepre.2018.12.003_bib0021","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jsat.2009.05.009","article-title":"Substance use treatment barriers for patients with frequent hospital admissions","volume":"38","author":"Raven","year":"2010","journal-title":"J Subst Abuse Treat"},{"issue":"8","key":"10.1016\/j.amepre.2018.12.003_bib0022","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1176\/appi.ps.201600339","article-title":"Reducing behavioral health inpatient readmissions for people with substance use disorders: do follow-up services matter?","volume":"68","author":"Reif","year":"2017","journal-title":"Psychiatr Serv"},{"issue":"8","key":"10.1016\/j.amepre.2018.12.003_bib0023","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1007\/s11606-017-4077-z","article-title":"Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity","volume":"32","author":"Wakeman","year":"2017","journal-title":"J Gen Intern Med"},{"issue":"2","key":"10.1016\/j.amepre.2018.12.003_bib0024","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jsat.2008.10.004","article-title":"Continuing care research: what we have learned and where we are going","volume":"36","author":"McKay","year":"2009","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"10.1016\/j.amepre.2018.12.003_bib0025","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13063-018-2466-1","article-title":"Effects of automated smartphone mobile recovery support and telephone continuing care in the treatment of alcohol use disorder: study protocol for a randomized controlled trial","volume":"19","author":"McKay","year":"2018","journal-title":"Trials"},{"issue":"1","key":"10.1016\/j.amepre.2018.12.003_bib0026","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/ajad.12161","article-title":"Initiating buprenorphine treatment for hospitalized patients with opioid dependence: a case series","volume":"24","author":"Suzuki","year":"2015","journal-title":"Am J Addict"},{"issue":"4","key":"10.1016\/j.amepre.2018.12.003_bib0027","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2149","article-title":"Primary care-based models for the treatment of opioid use disorder: a scoping review","volume":"166","author":"Korthuis","year":"2017","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.amepre.2018.12.003_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M15-0038","article-title":"Opioid prescribing after nonfatal overdose and association with repeated overdose: a cohort study","volume":"164","author":"Larochelle","year":"2016","journal-title":"Ann Intern Med"},{"issue":"3","key":"10.1016\/j.amepre.2018.12.003_bib0029","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jsat.2013.04.002","article-title":"Perceived relapse risk and desire for medication assisted treatment among persons seeking inpatient opiate detoxification","volume":"45","author":"Bailey","year":"2013","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.amepre.2018.12.003_bib0030","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsat.2016.07.004","article-title":"Post-discharge treatment engagement among patients with an opioid-use disorder","volume":"69","author":"Naeger","year":"2016","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.amepre.2018.12.003_bib0031","series-title":"Medication and counseling treatment","year":"2015"},{"issue":"6","key":"10.1016\/j.amepre.2018.12.003_bib0032","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s11920-017-0783-9","article-title":"Update on barriers to pharmacotherapy for opioid use disorders","volume":"19","author":"Sharma","year":"2017","journal-title":"Curr Psychiatry Rep"},{"issue":"6","key":"10.1016\/j.amepre.2018.12.003_bib0033","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1377\/hlthaff.2014.1205","article-title":"Growth in buprenorphine waivers for physicians increased potential access to opioid agonist treatment, 2002\u201311","volume":"34","author":"Dick","year":"2015","journal-title":"Health Aff (Millwood)"},{"issue":"1","key":"10.1016\/j.amepre.2018.12.003_bib0034","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1370\/afm.1735","article-title":"Geographic and specialty distribution of U.S. physicians trained to treat opioid use disorder","volume":"13","author":"Rosenblatt","year":"2015","journal-title":"Ann Fam Med"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379719300236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379719300236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T04:37:35Z","timestamp":1663303055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379719300236"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S0749379719300236"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2018.12.003","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"U.S. National 90-Day Readmissions After Opioid Overdose Discharge","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2018.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of American Journal of Preventive Medicine.","name":"copyright","label":"Copyright"}]}}